RMHYX | VBLAX | RMHYX / VBLAX | |
Total Expense Ratio | 0.34 | 0.06 | 567% |
Annual Report Gross Expense Ratio | 0.34 | 0.06 | 567% |
Fund Existence | 6 years | 6 years | - |
Gain YTD | 3.128 | -1.251 | -250% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000000 | 3000 | 333,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 401M | 8.42B | 5% |
Annual Yield % from dividends | 4.16 | 4.61 | 90% |
Returns for 1 year | 1.14 | -4.91 | -23% |
Returns for 3 years | 1.72 | -17.78 | -10% |
Returns for 5 years | -11.55 | -41.21 | 28% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DREGX | 41.89 | 0.15 | +0.36% |
Driehaus Emerging Markets Growth Inv | |||
CAFEX | 42.02 | 0.05 | +0.12% |
American Funds AMCAP 529E | |||
JMNSX | 16.21 | N/A | N/A |
JPMorgan Research Market Neutral I | |||
EPLDX | 22.68 | -0.04 | -0.18% |
NYLI Epoch U.S. Equity Yield Class R6 | |||
KMVAX | 36.51 | -0.13 | -0.35% |
Kirr Marbach Partners Value |